SeaStar Medical Holding Corporation
ICU
$0.31
$0.00-0.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,195.59% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,195.59% | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1,135.29% | -- | -- | -- | -- |
| SG&A Expenses | -23.23% | -16.74% | 5.92% | 5.16% | -21.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.06% | 5.91% | 31.67% | 24.76% | -14.27% |
| Operating Income | 14.11% | -0.70% | -28.56% | -23.82% | 14.63% |
| Income Before Tax | 54.26% | 55.04% | 50.05% | 5.36% | -18.71% |
| Income Tax Expenses | 250.00% | 250.00% | -- | -- | -140.00% |
| Earnings from Continuing Operations | 54.25% | 55.03% | 50.04% | 5.34% | -18.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.25% | 55.03% | 50.04% | 5.34% | -18.68% |
| EBIT | 14.11% | -0.70% | -28.56% | -23.82% | 14.63% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 87.33% | 87.52% | 85.58% | 76.42% | 71.53% |
| Normalized Basic EPS | 87.46% | 82.45% | 80.72% | 71.10% | 66.73% |
| EPS Diluted | 87.33% | 87.52% | 85.58% | 76.42% | 71.53% |
| Normalized Diluted EPS | 87.46% | 82.45% | 80.72% | 71.10% | 66.73% |
| Average Basic Shares Outstanding | 346.92% | 253.76% | 269.27% | 328.57% | 384.92% |
| Average Diluted Shares Outstanding | 346.92% | 253.76% | 269.27% | 328.57% | 384.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |